Generation Bio Co reports results for the quarter ended in June - Earnings Summary

Generation Bio

03/08/2023 04:33

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted
loss
of 47 cents​​ per share for the quarter ended in June. The mean
expectation of eight analysts for the quarter was for a loss
of 50 cents per share.
    * Revenue was $880.00 thousand​; analysts expected $3.55
million. 
    * Generation Bio Co's reported EPS for the quarter was a
loss
of 47 cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Generation Bio Co shares had fallen by 13.8% this
quarter and
gained 20.6% so far this year.
    * The company reported a quarterly loss of $31.07 million.
    * Wall Street's median 12-month price target for Generation
Bio Co
is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 03:33 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.50          -0.47          Beat
 Mar. 31 2023      -0.46          -0.53          Missed
 Dec. 31 2022      -0.58          -0.55          Beat
 Sep. 30 2022      -0.67          -0.53          Beat